Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors

Clinical trial NCT06639256 · RECRUITING

Trial details

NCT number: NCT06639256
Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Safety Tolerability Efficacy

Start date: 2024-10-24
Primary completion: 2026-05-01
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.